Robuta

https://www.financialcontent.com/quote/NQ:NTLA/about
Intellia Therapeutics, Inc. has quickly become one of the most talked-about names in the biotechnology sector. Since its inception, the company has been at the...
intellia therapeuticscommon stockhistoryincnasdaq
https://www.ad-hoc-news.de/boerse/news/ueberblick/ark-invest-amplifies-stake-in-intellia-therapeutics-ahead-of-critical-data/68483647
Intellia Therapeutics US45826J1051
ark investintellia therapeuticsstakeaheadcritical
https://www.ainvest.com/news/cathie-wood-ark-invest-doubles-intellia-therapeutics-major-workforce-reduction-2501/
Cathie Wood's Ark Invest Doubles Down on Intellia Therapeutics Despite Major Workforce Reduction
cathie woodark investintellia therapeuticsdoubles
https://www.biospace.com/press-releases/intellia-therapeutics-to-hold-conference-call-to-discuss-first-quarter-2025-earnings-and-company-updates
intellia therapeuticsconference callfirst quarterholddiscuss
https://www.businesswire.com/news/home/20240215392146/en/Intellia-Therapeutics-and-ReCode-Therapeutics-Announce-Strategic-Collaboration-to-Develop-Novel-Gene-Editing-Therapies-for-Cystic-Fibrosis
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, and...
intellia therapeuticsstrategic collaborationrecodeannouncedevelop